Population pharmacokinetics of micafungin in neonates and young infants.
Hope
William W
WW
The University of Manchester, Manchester Academic Health Science Centre, NIHR Translational Research Facility in Respiratory Medicine, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK. william.hope@manchester.ac.uk
Smith
P Brian
PB
Arrieta
Antonio
A
Buell
Donald N
DN
Roy
Michael
M
Kaibara
Atsunori
A
Walsh
Thomas J
TJ
Cohen-Wolkowiez
Michael
M
Benjamin
Daniel K
DK
D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D019540:Area Under Curve; D001499:Bayes Theorem; D002177:Candidiasis / Q000097:blood* / Q000188:drug therapy*; D054714:Echinocandins / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D055666:Lipopeptides / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D008590:Meningoencephalitis / Q000097:blood* / Q000188:drug therapy*; D008657:Metabolic Clearance Rate; D000077551:Micafungin; D008954:Models, Biological; D009010:Monte Carlo Method; D013577:Syndrome
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D000077551:Micafungin